首页 › 基金 › Ikarian Capital, LLC › MNPR

Ikarian Capital, LLC 对 MNPR 的持仓历史

MONOPAR THERAPEUTICS INC · 医疗保健

Ikarian Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 MNPR(MONOPAR THERAPEUTICS INC)86,761 股,市值约 US$6.9M,约占其申报组合的 1.01%,在其申报持仓中市值排名第 24 位。 Ikarian Capital, LLC 最近 8 个申报季度中有 4 个季度披露了 MNPR 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q3 2026)86.76K 股
申报持仓市值$6.91M
组合权重1.01%
首次申报Q4 2024
最近变动增持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Ikarian Capital, LLC 对 MNPR 的持仓演变

Ikarian Capital, LLC 于 Q4 2024 首次披露 MNPR 持仓:5,908 股(约 US$130K)。 该持仓在 Q3 2026 达到峰值 86,761 股,市值约 US$6.9M。 在 4 次申报中,Ikarian Capital, LLC 1 次增持、0 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 86,761 股、市值约 US$6.9M,环比增持 38,900 股。。 持仓曾出现大幅变动:Q3 2026 增持约 81% (随后一个季度股价下跌 10%)。

逐季持仓明细

季度股数金额变化
Q4 2024 5.91K $129.98K 新进
Q1 2025 5.91K $215.11K 持有
Q2 2026 47.86K $4.43M 新进
Q3 2026 86.76K $6.91M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 MNPR 与 13F 数据

MNPR(MONOPAR THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 69 只申报持有 MNPR,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$53.2M), Saturn V Capital Management LP (US$24.9M), Siren, L.L.C. (US$21.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 MNPR 的基金

查看 MNPR 的全部基金持有人 →

常见问题

How long has Ikarian Capital, LLC held MNPR?

Ikarian Capital, LLC has disclosed MNPR holdings in 4 of the last 8 reported quarters, going back to Q4 2024.

What is Ikarian Capital, LLC's current position in MNPR?

As of Q3 2026, Ikarian Capital, LLC holds 86.76K shares of MNPR (MONOPAR THERAPEUTICS INC), valued at $6.91M, representing 1.01% of its reported portfolio and ranking #24.

Has Ikarian Capital, LLC been buying or selling MNPR?

In the latest 13F filing (Q3 2026), Ikarian Capital, LLC increased its position in MNPR. The position peaked in Q3 2026 at 86.76K shares.

Which other funds hold MNPR?

Other major institutional holders of MNPR include RA CAPITAL MANAGEMENT, L.P., Saturn V Capital Management LP, Siren, L.L.C., among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.